New study by the team of Professor Gosse Adema demonstrates how cell avidity can be used to assess the effect of lead compounds on immune cells.
j.yeh22 March 2022
Dr. Maher’s powerful research underscores the insights that our revolutionary technology can help researchers around the world discover, and help science better address core challenges in human health, particularly in designing potentially more effective immunotherapies to fight cancer.
j.yeh17 March 2022
LUMICKS has announced that it has completed installation and training for its 100th customer sale at the MRC-LMB, marking an important milestone in the company’s growth from a start-up in 2015.
j.yeh14 March 2022
